{"id":10132,"date":"2017-10-18T13:37:00","date_gmt":"2017-10-18T21:37:00","guid":{"rendered":"http:\/\/www.foodanddrugrecall.org\/index.php\/fda-approves-car-t-cell-therapy-to-treat-adults-with-certain-types-of-large-b-cell-lymphoma\/"},"modified":"2017-10-18T13:37:00","modified_gmt":"2017-10-18T21:37:00","slug":"fda-approves-car-t-cell-therapy-to-treat-adults-with-certain-types-of-large-b-cell-lymphoma","status":"publish","type":"post","link":"https:\/\/www.foodanddrugrecall.org\/index.php\/fda-approves-car-t-cell-therapy-to-treat-adults-with-certain-types-of-large-b-cell-lymphoma\/","title":{"rendered":"FDA approves CAR-T cell therapy to treat adults with certain types of large B-cell lymphoma"},"content":{"rendered":"<p>The U.S. Food and Drug Administration today approved Yescarta (axicabtagene ciloleucel), a cell-based gene therapy, to treat adult patients with certain types of large B-cell lymphoma who have not responded to or who have relapsed after at least two other kinds of treatment. Yescarta, a chimeric antigen receptor (CAR) T cell therapy, is the second gene therapy approved by the FDA and the first for certain types of non-Hodgkin lymphoma (NHL).<\/p>\n","protected":false},"excerpt":{"rendered":"<p>The U.S. Food and Drug Administration today approved Yescarta (axicabtagene ciloleucel), a cell-based gene therapy, to treat adult patients with certain types of large B-cell lymphoma who have not responded to or who have relapsed after at least two other kinds of treatment. Yescarta, a chimeric antigen receptor (CAR) T cell therapy, is the second &hellip; <a href=\"https:\/\/www.foodanddrugrecall.org\/index.php\/fda-approves-car-t-cell-therapy-to-treat-adults-with-certain-types-of-large-b-cell-lymphoma\/\" class=\"more-link\">Continue reading <span class=\"screen-reader-text\">FDA approves CAR-T cell therapy to treat adults with certain types of large B-cell lymphoma<\/span> <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"1","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[14,4,3,6],"tags":[],"class_list":["post-10132","post","type-post","status-publish","format-standard","hentry","category-drug-reacalls-safety-notices-information","category-drug-safety-information-podcasts","category-food-drug-recalls","category-food-safety-news"],"_links":{"self":[{"href":"https:\/\/www.foodanddrugrecall.org\/index.php\/wp-json\/wp\/v2\/posts\/10132","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.foodanddrugrecall.org\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.foodanddrugrecall.org\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.foodanddrugrecall.org\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.foodanddrugrecall.org\/index.php\/wp-json\/wp\/v2\/comments?post=10132"}],"version-history":[{"count":0,"href":"https:\/\/www.foodanddrugrecall.org\/index.php\/wp-json\/wp\/v2\/posts\/10132\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.foodanddrugrecall.org\/index.php\/wp-json\/wp\/v2\/media?parent=10132"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.foodanddrugrecall.org\/index.php\/wp-json\/wp\/v2\/categories?post=10132"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.foodanddrugrecall.org\/index.php\/wp-json\/wp\/v2\/tags?post=10132"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}